NorthStar marks milestone in non-uranium production of Mo-99
January 12, 2023, 12:02PMNuclear News

IBA Rhodotron TT300-HE (high energy) electron accelerator. (Photo: Business Wire)
Nuclear medicine company NorthStar Medical Radioisotopes announced that it has successfully produced molybdenum-99 at its recently completed accelerator production facility at its Beloit, Wis., campus. According to NorthStar, the event marks a major milestone in advancing the company’s proprietary electron accelerator technology for the non-uranium–based production of the critical medical radioisotope.
Tags:
Share: